30/08/2017 (Agence Europe) – The European Parliament will ensure that the new headquarters of the European Medicines Agency (EMA) will be chosen in full transparency, in the interests of safeguarding citizens health, while promoting innovation. This is the substance of the statement made by the Parliament's President, Antonio Tajani, following his meeting with the Executive Director of the European Medicines Agency (EMA), Professor Guido Rasi. In a press release, he argued that,...